Whitehead, Kathryn A.
Dorkin, J. Robert
Vegas, Arturo J.
Chang, Philip H.
Veiseh, Omid
Matthews, Jonathan
Fenton, Owen S.
Zhang, Yunlong
Olejnik, Karsten T.
Yesilyurt, Volkan
Chen, Delai
Barros, Scott
Klebanov, Boris
Novobrantseva, Tatiana
Langer, Robert
Anderson, Daniel G.
Article History
Received: 25 November 2013
Accepted: 2 June 2014
First Online: 27 June 2014
Competing interests
: R.L. is a shareholder and member of the scientific advisory board of Alnylam. D.G.A. is a consultant with Alnylam Pharmaceuticals. R.L. and D.G.A. have sponsored research grants from Alnylam. Alnylam also has a license to certain intellectual property invented at Massachusetts Institute of Technology by K.A.W., J.R.D., A.J.V., R.L., and D.G.A. The remaining authors declare no competing financial interest.